“migalastat” Archives

in
Entry Author Date Location
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Amicus Shells Out $100M For Celenex And Dives Into Gene Therapy 09/20/18 New York
FDA, Following EMA, Nixes Amicus’ Plans for Speedy OK of Pompe Drug 09/10/18 New York
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals 08/10/18 New York
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 09/13/17 New York
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
At Long Last, First Drug Approval in Sight for Amicus 04/01/16 New York
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
With Data in Hand, Amicus Preps For Drug Filings in U.S., Europe 03/19/15 New York
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
With Persistence And Phase 3 Win, Amicus Nears First Drug Approval 08/20/14 New York
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Page 1 of 1